{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-005925","form_type":"8-K","ticker":"CCRN","cik":"0001141103","company_name":"CROSS COUNTRY HEALTHCARE INC","filed_at":"2024-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.505923+00:00","generated_at":"2026-06-05T21:42:53.857319+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cross Country Healthcare CCO Daniel J. White to depart March 31, 2024","bullets":["Chief Commercial Officer Daniel J. White will leave the company on March 31, 2024 under a separation agreement.","Agreement provides for continued base salary payments for six months following his departure.","No successor or interim appointment has been disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-005925","json":"https://secwatch.observer/filing/0001628280-24-005925.json","markdown":"https://secwatch.observer/filing/0001628280-24-005925.md","text":"https://secwatch.observer/filing/0001628280-24-005925.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1141103/000162828024005925/0001628280-24-005925-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1141103/000162828024005925/ccrn-20240214.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T21:42:53.857319+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c689ca7401","claim":"Daniel J. White departed as Chief Commercial Officer at CROSS COUNTRY HEALTHCARE INC.","evidence_excerpt":"On February 14, 2024, Cross Country Healthcare, Inc. (the “Company”) entered into a separation agreement (the “Agreement”) with Daniel J. White, Chief Commercial Officer. Under the Agreement, Mr. White will depart the Company on March 31, 2024 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1141103/000162828024005925/0001628280-24-005925-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will depart"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}